ID PTPRV_MOUSE Reviewed; 1705 AA. AC P70289; DT 15-JUL-1998, integrated into UniProtKB/Swiss-Prot. DT 01-FEB-1997, sequence version 1. DT 27-MAR-2024, entry version 144. DE RecName: Full=Receptor-type tyrosine-protein phosphatase V; DE Short=R-PTP-V; DE EC=3.1.3.48 {ECO:0000269|PubMed:20655470}; DE AltName: Full=Embryonic stem cell protein-tyrosine phosphatase; DE Short=ES cell phosphatase; DE Flags: Precursor; GN Name=Ptprv; Synonyms=Esp; OS Mus musculus (Mouse). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae; OC Murinae; Mus; Mus. OX NCBI_TaxID=10090; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA]. RC TISSUE=Embryonic stem cell; RX PubMed=8951793; DOI=10.1016/0925-4773(96)00586-2; RA Lee K., Nichols J., Smith A.; RT "Identification of a developmentally regulated protein tyrosine phosphatase RT in embryonic stem cells that is a marker of pluripotential epiblast and RT early mesoderm."; RL Mech. Dev. 59:153-164(1996). RN [2] RP ERRATUM OF PUBMED:8951793. RA Lee K., Nichols J., Smith A.; RL Mech. Dev. 61:213-215(1996). RN [3] RP FUNCTION, AND DISRUPTION PHENOTYPE. RX PubMed=17693256; DOI=10.1016/j.cell.2007.05.047; RA Lee N.K., Sowa H., Hinoi E., Ferron M., Ahn J.D., Confavreux C., RA Dacquin R., Mee P.J., McKee M.D., Jung D.Y., Zhang Z., Kim J.K., RA Mauvais-Jarvis F., Ducy P., Karsenty G.; RT "Endocrine regulation of energy metabolism by the skeleton."; RL Cell 130:456-469(2007). RN [4] RP FUNCTION, AND CATALYTIC ACTIVITY. RX PubMed=20655470; DOI=10.1016/j.cell.2010.06.003; RA Ferron M., Wei J., Yoshizawa T., Del Fattore A., DePinho R.A., Teti A., RA Ducy P., Karsenty G.; RT "Insulin signaling in osteoblasts integrates bone remodeling and energy RT metabolism."; RL Cell 142:296-308(2010). CC -!- FUNCTION: Protein tyrosine phosphatase that acts as a regulator of CC energy metabolism by mediating dephosphorylation of insulin receptor CC (Insr) (PubMed:17693256, PubMed:20655470). Prevents decarboxylation of CC osteocalcin (Bglap and Bglap2) via an indirect mechanism: CC dephosphorylation of insulin receptor prevents insulin signaling- CC dependent decarboxylation of osteocalcin, preventing the hormone CC activity of osteocalcin (PubMed:17693256, PubMed:20655470). May play a CC role in the maintenance of pluripotency (PubMed:8951793). CC {ECO:0000269|PubMed:17693256, ECO:0000269|PubMed:20655470, CC ECO:0000269|PubMed:8951793}. CC -!- CATALYTIC ACTIVITY: CC Reaction=H2O + O-phospho-L-tyrosyl-[protein] = L-tyrosyl-[protein] + CC phosphate; Xref=Rhea:RHEA:10684, Rhea:RHEA-COMP:10136, Rhea:RHEA- CC COMP:10137, ChEBI:CHEBI:15377, ChEBI:CHEBI:43474, ChEBI:CHEBI:46858, CC ChEBI:CHEBI:82620; EC=3.1.3.48; Evidence={ECO:0000255|PROSITE- CC ProRule:PRU10044, ECO:0000269|PubMed:20655470}; CC -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane protein. CC -!- DEVELOPMENTAL STAGE: Detectable in the epiblast of oocytes and CC throughout early mouse embryo development (PubMed:8951793). In adult, CC expression is localized in gonadal germ cells (PubMed:8951793). CC {ECO:0000269|PubMed:8951793}. CC -!- INDUCTION: Down-regulated during cell differentiation. CC {ECO:0000269|PubMed:8951793}. CC -!- DISRUPTION PHENOTYPE: Mice are hypoglycemic and are protected from CC obesity and glucose intolerance because of an increase in beta-cell CC proliferation, insulin secretion, and insulin sensitivity. CC {ECO:0000269|PubMed:17693256}. CC -!- SIMILARITY: Belongs to the protein-tyrosine phosphatase family. CC Receptor class 3 subfamily. {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; U36488; AAC52868.1; -; mRNA. DR AlphaFoldDB; P70289; -. DR SMR; P70289; -. DR GlyCosmos; P70289; 19 sites, No reported glycans. DR GlyGen; P70289; 19 sites. DR PeptideAtlas; P70289; -. DR AGR; MGI:108027; -. DR MGI; MGI:108027; Ptprv. DR InParanoid; P70289; -. DR PRO; PR:P70289; -. DR Proteomes; UP000000589; Unplaced. DR RNAct; P70289; Protein. DR GO; GO:0016020; C:membrane; IEA:UniProtKB-SubCell. DR GO; GO:0004725; F:protein tyrosine phosphatase activity; IDA:UniProtKB. DR GO; GO:0044242; P:cellular lipid catabolic process; IMP:MGI. DR GO; GO:0032869; P:cellular response to insulin stimulus; IMP:MGI. DR GO; GO:0016311; P:dephosphorylation; IEA:InterPro. DR GO; GO:0006977; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; IGI:MGI. DR GO; GO:0048144; P:fibroblast proliferation; IMP:MGI. DR GO; GO:0042593; P:glucose homeostasis; IMP:MGI. DR GO; GO:0031571; P:mitotic G1 DNA damage checkpoint signaling; IMP:MGI. DR GO; GO:0048147; P:negative regulation of fibroblast proliferation; IMP:MGI. DR GO; GO:0046676; P:negative regulation of insulin secretion; IMP:MGI. DR GO; GO:0031016; P:pancreas development; IMP:MGI. DR GO; GO:0044342; P:type B pancreatic cell proliferation; IMP:MGI. DR CDD; cd00063; FN3; 3. DR CDD; cd14618; R-PTPc-V; 1. DR Gene3D; 2.60.40.10; Immunoglobulins; 5. DR Gene3D; 3.90.190.10; Protein tyrosine phosphatase superfamily; 2. DR InterPro; IPR003961; FN3_dom. DR InterPro; IPR036116; FN3_sf. DR InterPro; IPR013783; Ig-like_fold. DR InterPro; IPR029021; Prot-tyrosine_phosphatase-like. DR InterPro; IPR000242; PTP_cat. DR InterPro; IPR041201; PTPRJ_TM. DR InterPro; IPR016130; Tyr_Pase_AS. DR InterPro; IPR003595; Tyr_Pase_cat. DR InterPro; IPR000387; Tyr_Pase_dom. DR PANTHER; PTHR46957; CYTOKINE RECEPTOR; 1. DR PANTHER; PTHR46957:SF6; PROTEIN-TYROSINE-PHOSPHATASE; 1. DR Pfam; PF00041; fn3; 3. DR Pfam; PF18861; PTP_tm; 1. DR Pfam; PF00102; Y_phosphatase; 2. DR PRINTS; PR00700; PRTYPHPHTASE. DR SMART; SM00060; FN3; 9. DR SMART; SM00194; PTPc; 1. DR SMART; SM00404; PTPc_motif; 2. DR SUPFAM; SSF52799; (Phosphotyrosine protein) phosphatases II; 2. DR SUPFAM; SSF49265; Fibronectin type III; 8. DR PROSITE; PS50853; FN3; 5. DR PROSITE; PS00383; TYR_PHOSPHATASE_1; 1. DR PROSITE; PS50056; TYR_PHOSPHATASE_2; 1. DR PROSITE; PS50055; TYR_PHOSPHATASE_PTP; 2. PE 1: Evidence at protein level; KW Glycoprotein; Hydrolase; Membrane; Protein phosphatase; Reference proteome; KW Repeat; Signal; Transmembrane; Transmembrane helix. FT SIGNAL 1..18 FT /evidence="ECO:0000255" FT CHAIN 19..1705 FT /note="Receptor-type tyrosine-protein phosphatase V" FT /id="PRO_0000025466" FT TOPO_DOM 19..1077 FT /note="Extracellular" FT /evidence="ECO:0000255" FT TRANSMEM 1078..1100 FT /note="Helical" FT /evidence="ECO:0000255" FT TOPO_DOM 1101..1705 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT DOMAIN 37..129 FT /note="Fibronectin type-III 1" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00316" FT DOMAIN 130..222 FT /note="Fibronectin type-III 2" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00316" FT DOMAIN 218..305 FT /note="Fibronectin type-III 3" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00316" FT DOMAIN 306..388 FT /note="Fibronectin type-III 4" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00316" FT DOMAIN 393..454 FT /note="Fibronectin type-III 5" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00316" FT DOMAIN 475..569 FT /note="Fibronectin type-III 6" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00316" FT DOMAIN 565..654 FT /note="Fibronectin type-III 7" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00316" FT DOMAIN 655..749 FT /note="Fibronectin type-III 8" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00316" FT DOMAIN 744..831 FT /note="Fibronectin type-III 9" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00316" FT DOMAIN 832..926 FT /note="Fibronectin type-III 10" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00316" FT DOMAIN 1150..1409 FT /note="Tyrosine-protein phosphatase 1" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00160" FT DOMAIN 1427..1695 FT /note="Tyrosine-protein phosphatase 2" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00160" FT REGION 24..44 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT ACT_SITE 1350 FT /note="Phosphocysteine intermediate" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00160, FT ECO:0000255|PROSITE-ProRule:PRU10044" FT BINDING 1316 FT /ligand="substrate" FT /evidence="ECO:0000250" FT BINDING 1350..1356 FT /ligand="substrate" FT /evidence="ECO:0000250" FT BINDING 1394 FT /ligand="substrate" FT /evidence="ECO:0000250" FT CARBOHYD 74 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 89 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 117 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 174 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 239 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 259 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 299 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 345 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 431 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 551 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 570 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 620 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 649 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 663 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 737 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 851 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 882 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 970 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 982 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" SQ SEQUENCE 1705 AA; 186796 MW; 2783755F15387D5B CRC64; MRPLILLAAL LWLQDSLAQE DVCSSLDGSP DRQGGGPPLS VSVTSRGRPT SLFLSWVAAE PGGFDYALCL RAMNLSGFPE GQQLQAHTNE SSFEFHGLVP GSRYQLELTV LRPCWQNVTI TLTARTAPTV VRGLQLHSTG SPASLEASWS DASGDQDSYQ LLLYHPESHT LACNVSVSPD TLSYNFGDLL PGSQYVLEVI TWAGSLHAKT SILQWTEPVP PDHLRVRALG TSSLQAFWNS SEGATWFHLI LTDLLEGTNL TKVVRQGIST HTFLRLSPGT PYQLKICAAA GPHQIWGPNA TEWTYPSYPS DLVLTPLWNE LWASWKAGQG ARDGYVLKLS GPVENTTTLG PEECNAVFPG PLPPGHYTLG LRVLAGPYDA WVEGSIWLAE SAARPMEVPG ARLWLEGLEA TKQPGRRALL YSVDAPGLLG NISVSSGATH VTFCGLVPGA HYRVDIASSM GDITQSLTGY TSPLPPQSLE IISRNSPSDL TIGWAPAPGQ MEGYKVTWHQ DGSQRSPGDL VDLGPDISSL TLKSLVPGSC YTVSAWAWSG NLSSDSQKIH SCTRPAPPTN LSLGFAHQPA TLRASWCHPP GGRDAFQLRL YRLRPLTLES EKILSQEAQN FSWAQLPAGY EFQVQLSTLW GSEESGSANT TGWTPPSAPT LVNVTSEAPT QLHVSWVHAA GDRSSYQVTL YQESTRTATS IVGPKADSTS FWGLTPGTKY KVEAISWAGP LYTAAANVSA WTYPLTPNEL LASMQAGSAV VNLAWPSGPL GRGTCHAQLS DAGHLSWEQP LSLGQDLLML RNLIPGHTVS LSVKCRAGPL QASTHPLVLS VEPGPVEDVF CQPEATYLSL NWTMPTGDVA VCLVEVEQLV PGGSAHFVFQ VNTSEDALLL PNLTPTTSYR LSLTVLGGNR QWSRAVTLVC TTSAEVWHPP ELAEAPQVEL GTGMGVTVTR GMFGKDDGQI QWYGIIATIN MTLAQPSQEA INHTWYDHYY RGHDSYLALL FPNPFYPEPW AVPRSWTVPV GTEDCDNTQE ICNGHLKPGF QYRFSIAAFS RLSSPETILA FSAFSEPQAS ISLVAMPLTV MMGTVVGCII IVCAVLCLLC RRGLKGPRSE KNGFSQELMP YNLWRTHRPI PSHSFRQSYE AKSARAHQAF FQEFEELKEV GKDQPRLEAE HPANITKNRY PHVLPYDHSR VRLTQLSGEP HSDYINANFI PGYSHPQEII ATQGPLKKTV EDFWRLVWEQ QVHVIIMLTV GMENGRVLCE HYWPVNSTPV THGHITTHLL AEESEDEWTR REFQLQHGAE QKQRRVKQLQ FTTWPDHSVP EAPSSLLAFV ELVQEEVKAT QGKGPILVHC SAGVGRTGTF VALLPAVRQL EEEQVVDVFN TVYILRLHRP LMIQTLSQYI FLHSCLLNKI LEGPSDASDS GPIPVMNFAQ ACAKRAANAN AGFLKEYRLL KQAIKDETGS LLPSPDYNQN SIASCHHSQE QLALVEESPA DNMLAASLFP GGPSGRDHVV LTGSAGPKEL WEMVWEHGAY VLVSLGLPDT KEKPQDIWPM EMQPIVTDMV TVHRVAESNT AGWPSTLIRV IHGDSGTERQ VQCLQFPHCE TGSELPANTL LTFLDAVGQC CSRGNSKKPG TLLSHSSKVT NQLSTFLAME QLLQQAGTER TVDVFSVALK QTQACAVKTP TLEQYIYLYN CLNSALRNRL PRARK //